These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17868047)

  • 21. Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma.
    Lee MY; Tsou MH; Tan TD; Lu MC
    Eur J Haematol; 2005 Sep; 75(3):221-6. PubMed ID: 16104878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology review for paediatric non-Hodgkin's lymphoma patients in Japan; a report from the Japan association of childhood leukaemia study (JACLS).
    Nakagawa A; Nakamura S; Nakamine H; Yoshino T; Takimoto T; Horibe K; Ueda K
    Eur J Cancer; 2004 Mar; 40(5):725-33. PubMed ID: 15010074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric lymphoma in China: a clinicopathological study of 213 cases.
    Wang J; Wu X; Shen Y; Xi Z
    Pathology; 2012 Dec; 44(7):622-5. PubMed ID: 23149377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group.
    Kontny U; Oschlies I; Woessmann W; Burkhardt B; Lisfeld J; Salzburg J; Janda A; Attarbaschi A; Niggli F; Zimmermann M; Reiter A; Klapper W
    Br J Haematol; 2015 Mar; 168(6):835-44. PubMed ID: 25395120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
    Porcu P; Nichols CR
    Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
    Reismüller B; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Dieckmann K; Henze G; Haas OA; Gadner H; Mann G;
    Br J Haematol; 2009 Feb; 144(4):559-70. PubMed ID: 19077160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retrospective analysis of 54 patients with high risk aggressive T-cell non-Hodgkin lymphomas].
    Yuan XL; Li QC; Zou DH; Zhao YZ; Wang YF; Wang Y; Zhang JW; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):454-7. PubMed ID: 18072627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
    Vose J; Armitage J; Weisenburger D;
    J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science.
    Hochberg J; Waxman IM; Kelly KM; Morris E; Cairo MS
    Br J Haematol; 2009 Jan; 144(1):24-40. PubMed ID: 19087093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
    Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
    J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetic study on 155 cases of non-Hodgkin' s lymphoma].
    Wang XQ;
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):656-60. PubMed ID: 17343195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas.
    Novakovic BJ; Novakovic S; Frkovic-Grazio S
    Oncol Rep; 2006 Jul; 16(1):191-5. PubMed ID: 16786145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
    Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
    Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric non-Hodgkin lymphoma: a retrospective 14-year experience with Berlin-Frankfurt-Münster (BFM) protocols from a tertiary care hospital in Serbia.
    Dokmanovic L; Krstovski N; Vukanic D; Brasanac D; Rodic P; Cvetkovic M; Janic D
    Pediatr Hematol Oncol; 2012 Mar; 29(2):109-18. PubMed ID: 22376014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials.
    Seidemann K; Tiemann M; Henze G; Sauerbrey A; Müller S; Reiter A
    Med Pediatr Oncol; 1999 Dec; 33(6):536-44. PubMed ID: 10573576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
    Luminari S; Cesaretti M; Rashid I; Mammi C; Montanini A; Barbolini E; Bellei M; Pennese E; Sirotti MA; Marcheselli L; Partesotti G; Bari A; Maiorana A; Bonacorsi G; Federico M
    Hematol Oncol; 2007 Dec; 25(4):189-97. PubMed ID: 17654762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.